Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

News and Announcements

CRYPTO20 Reaches Minimum Fund Cap Within Hours of Pre-Sale

  • Published October 20, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • CRYPTO20 has attained their minimum fund cap after only hours of the pre-sale inauguration on 7 October 2017.
  • The autonomous crypto index fund aims at presenting peace-of-mind cryptocurrency investment to the mainstream investors.
  • A total of $5 million funds have been raised by the end of the CRYPTO20.

CRYPTO20, popular as the autonomous crypto index fund, which tracks the leading 20 cryptocurrencies, stated that they had attained their minimum fund cap after only hours of the pre-sale inauguration on 7 October 2017.

The goal of CRYPTO20 is to present peace-of-mind cryptocurrency investment to the mainstream investors. It maintains and autonomously rebalances a portfolio of the leading 20 cryptocurrencies proven by data science.

The actively managed funds have failed continuously to overcome the market index in spite of the billions of dollars, decades worth of data and hundreds of analysts within their reach. In cases where they have managed to overcome the market index, their fees have diluted the investor returns.

Because of the increasing crypto prices, the value of fund per each token surpassed the price of tokens under sale making the pre-sale investors capable of acquiring $1.10 of the underlying crypto assets for a price of $0.95 per token.

A total of $5 million funds has been raised by the end of the CRYPTO20 with over 2000 bankers coming from 93 countries participating. The main ICO commences on 16th October 2017 at 18:00 GMT and closes on 30th November at 00:00 GMT.

C20, the fund’s token, represents the share of the fund of an investor with the value of the fund being the same as that of the combined value of the assets. Unlike several other offerings available in the marketplace currently, CRYPTO20 is not a platform but rather a finished product.

CRYPTO20 has issued insights and trading tools that are created live from the eight exchanges that are appended to the system through API. These trading tools include information on the best price, slippage, the volume by exchange and the trading pair to obtain assets with.

The token-holders are allowed to liquidate the C20 token meant for their underlying assets share through the smart contract. CRYPTO20 offers investors the capacity to sell or exchange the tokens they have at will by going straight to the end-user. The fund works as a registered LLC in the Cayman Islands and is wholly AML/KYC compliant.

The CRYPTO20 fund alleviates the volatility and risk and has offered better returns than bitcoin.

Request Offer

Capital Insights
Wholesale Investor and CapitalHQ Sign Exclusive Master Licence with inQ Innovation Global to Provide Access to India’s High-Growth Startup Market

Wholesale Investor and inQ Innovation have forged a strategic partnership, granting global investors direct access to India’s rapidly expanding innovation ecosystem. This exclusive three-year agreement leverages CapitalHQ’s technology to streamline fundraising for Indian startups and expand deal flow for WI’s 45,000-strong investor network, aligning with India’s 2030 Vision for economic growth and innovation.

Capital Insights
EBR Systems: Aussie Medtech Ready to Disrupt $3.6B Heart Failure Market with Leadless Pacemaker

Andrew Shute, Senior Vice President of Business Development at EBR Systems, is confident that his Australian medical device company is poised to make a significant impact on the global cardiac rhythm management market. The focus? A novel leadless pacemaker designed to revolutionise treatment for heart failure patients. After years of development and rigorous clinical trials, […]

Join over 45,000+ sophisticated investors

Join Now